Gravie, a specialist in defined contribution healthcare, has raised USD28 million in a Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners.
The capital will be used to fuel Gravie’s continued growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels.
“We are excited to partner with AXA Venture Partners in our mission to heal our broken healthcare system,” says Abir Sen, co-founder and Executive Chairman of Gravie.
“Gravie is revolutionising how businesses and their employees access the healthcare system,” says Alex Scherbakovsky, AVP General Partner. “We are proud to partner with Abir and the Gravie team to scale the company.”
Read more at Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.